Furthermore, GEP in EBV+ DLBCL has demonstrated upregulation of NF-κB signalling and pathways involved in proliferation, cell cycle progression, and metabolism compared to EBV-negative tumours [104]. Here, NFKB1 is linked to neoplasm.